Discover
TMO
Thermo Fisher Scientific Inc.
605.00
1 x 600.05
1 x 608.00
bid
ask
+
5.31
0.89%
600 @ 04:00 PM
605.00 +0.00 (0.00%)
| Ytd | 4.41% | |
| 1y | 30.84% |
594.81
day range
606.21
435.27
52 week range
643.99
| Open | 599.99 | Prev Close | 599.69 | Low | 594.81 | High | 606.21 | Mkt Cap | 224.83B |
| Vol | 0.00 | Avg Vol | 2.32M | EPS | 23.16 | P/E | 26.12 | Forward P/E | 21.59 |
| Beta | 0.85 | Short Ratio | 2.52 | Inst. Own | 93.83% | Dividend | 1.88 | Div Yield | 0.32 |
| Ex Div Date | 09-15 | Earning | 07-23 | 50-d Avg | 519.80 | 200-d Avg | 532.02 | 1yr Est | 631.42 |
| Income Statement | |||
| Total Revenue | 11.99B | ||
| Revenues (USD) | 11.99B | ||
| Cost of Revenue | 7.11B | ||
| Gross Profit | 4.88B | ||
| Operating Expenses | 2.80B | ||
| Research and Development Expense | 364.00M | ||
| Selling, General and Administrative Expense | 2.33B | ||
| Operating Income | 2.09B | ||
| Interest Expense | 401.00M | ||
| Income Tax Expense | 167.00M | ||
| Net Income | 1.74B | ||
| Net Income Common Stock | 1.74B | ||
| Net Income Common Stock (USD) | 1.74B | ||
| Consolidated Income | 1.74B | ||
| Net Income to Non-Controlling Interests | 5.00M | ||
| Earnings per Basic Share | 4.68 | ||
| Earnings per Basic Share (USD) | 4.68 | ||
| Earnings per Diluted Share | 4.68 | ||
| Dividends per Basic Common Share | 0.47 | ||
| Earning Before Interest & Taxes (EBIT) | 2.30B | ||
| Earning Before Interest & Taxes (USD) | 2.30B | ||
| Weighted Average Shares | 371.00M | ||
| Weighted Average Shares Diluted | 371.00M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.06B | ||
| Cash and Equivalents (USD) | 4.06B | ||
| Trade and Non-Trade Receivables | 9.45B | ||
| Current Assets | 23.37B | ||
| Property, Plant & Equipment Net | 10.76B | ||
| Total Assets | 113.17B | ||
| Debt Current | 3.37B | ||
| Total Debt | 42.55B | ||
| Current Liabilities | 15.07B | ||
| Debt Non-Current | 39.18B | ||
| Total Liabilities | 60.49B | ||
| Accumulated Retained Earnings (Deficit) | 62.19B | ||
| Accumulated Other Comprehensive Income | -2.46B | ||
| Shareholders Equity | 52.68B | ||
| Shareholders Equity (USD) | 52.68B | ||
| Assets Non-Current | 89.81B | ||
| Total Debt (USD) | 42.55B | ||
| Deferred Revenue | 2.92B | ||
| Goodwill and Intangible Assets | 73.44B | ||
| Inventory | 5.63B | ||
| Liabilities Non-Current | 45.42B | ||
| Trade and Non-Trade Payables | 3.27B | ||
| Tax Liabilities | 1.58B | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 817.00M | ||
| Net Cash Flow from Financing | -1.57B | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 817.00M | ||
| Capital Expenditure | -446.00M | ||
| Issuance (Purchase) of Equity Shares | -1000.00M | ||
| Issuance (Repayment) of Debt Securities | -389.00M | ||
| Payment of Dividends & Other Cash Distributions | -175.00M | ||
| Net Cash Flow from Investing | 164.00M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -18.00M | ||
| Net Cash Flow from Operations | 2.13B | ||
| Effect of Exchange Rate Changes on Cash | 98.00M | ||
| Share Based Compensation | 82.00M | ||